FrancophonIA/ELRC3.0 huggingface dataset:
English: Clinical signs and symptoms of mild and moderate OHSS are abdominal pain, nausea, diarrhoea, mild to moderate enlargement of ovaries and ovarian cysts.
Slovenian: Klinični znaki in simptomi blagega in zmernega OHSS so trebušne bolečine, slabost, driska, blago do zmerno povečanje jajčnikov in ciste na jajčnikih.
English: Medical conditions that contraindicate pregnancy should also be evaluated before starting treatment with Elonva.
Slovenian: Prav tako je treba pred začetkom zdravljenja z zdravilom Elonva oceniti bolezenska stanja, pri katerih je nosečnost kontraindicirana.
English: *Live birth rate was a secondary efficacy endpoint in ENGAGE and PURSUE.
Slovenian: *Delež živorojenih je bil v študijah ENGAGE in PURSUE sekundarni opazovani dogodek.
English: Store at or below 25°C for a period of not more than 1 month.
Slovenian: Shranjujte pri temperaturi do 25 C za obdobje največ 1 meseca.
English: In these clinical trials, the safety profile of a single injection with Elonva was comparable to daily injections with recFSH.
Slovenian: Profil varnosti ene injekcije zdravila Elonva je bil v teh kliničnih preskušanjih podoben kot pri uporabi vsakodnevnih injekcij (rek)FSH.
English: Uncommon ( may affect up to 1 in 100 women) - Twisting of an ovary (ovarian torsion) - Liver enzyme increases - Miscarriage - Pain after oocyte retrieval - Procedural pain - Releasing an egg too early (premature ovulation) - Abdominal distension - Vomiting - Diarrhoea - Constipation - Back pain - Breast pain - Bruising or pain at the injection site - Irritability - Mood swings - Dizziness - Hot flush
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 uporabnic) - zasuk jajčnikov (torzija jajčnikov) - zvišanje jetrnih encimov - spontani splav - bolečina po odvzemu jajčeca - bolečina ob postopku - prezgodnja sprostitev jajčeca (prezgodnja ovulacija) - napihnjenost trebuha - bruhanje - driska - zaprtost - bolečine v hrbtu - bolečine v dojkah - podplutba ali bolečina na mestu injiciranja - razdražljivost - nihanje razpoloženja - omotica - navali vročine
English: Elonva is used to help achieve pregnancy in women having infertility treatment, such as in vitro fertilisation (IVF).
Slovenian: Zdravilo Elonva uporabljamo za pomoč pri doseganju nosečnosti pri ženskah, ki se zdravijo zaradi neplodnosti, na primer z in vitro fertilizacijo (IVF).
English: A possible complication of treatment with gonadotropic hormones like Elonva is unwanted overstimulation of the ovaries.
Slovenian: Možen zaplet zdravljenja z gonadotropnimi hormoni, kakršno je zdravilo Elonva, je neželena hiperstimulacija jajčnikov.
English: In rare instances, venous or arterial thromboembolism may occur in association with OHSS.
Slovenian: V redkih primerih lahko v povezavi z OHSS nastopijo venski ali arterijski tromboembolizmi.
English: The co-primary efficacy endpoints were ongoing pregnancy rate and number of oocytes retrieved.
Slovenian: Primarna opazovana dogodka učinkovitosti sta bila delež potekajočih nosečnosti in število dobljenih jajčec.
English: The pregnancy results from the fresh cycles of ENGAGE and PURSUE are summarized in Table 2 below.
Slovenian: Rezultati nosečnosti iz ciklov z uporabo svežih zarodkov v študijah ENGAGE in PURSUE so povzeti v preglednici 2 spodaj.
English: o A basal antral follicle count > 20.
Slovenian: o bazalno število antralnih foliklov > 20,
English: - The other ingredients are: sodium citrate, sucrose, polysorbate 20, methionine and water for injections.
Slovenian: - Pomožne snovi so: natrijev citrat, saharoza, polisorbat 20, metionin in voda za injekcije.
English: Treatment with gonadotropic hormones like Elonva may cause ovarian hyperstimulation syndrome (OHSS).
Slovenian: Zdravljenje z gonadotropnimi hormoni, kakršen je zdravilo Elonva, lahko povzroči sindrom hiperstimulacije jajčnikov (OHSS).
English: Since the rate of elimination of corifollitropin alfa may be reduced in patients with renal insufficiency, the use of Elonva in these women is not recommended (see sections 4.4 and 5.2).
Slovenian: Ker je lahko pri teh bolnicah zmanjšana stopnja izločanja korifolitropina alfa, uporaba zdravila Elonva pri njih ni priporočljiva (glejte poglavji 4.4 in 5.2).
English: What Elonva looks like and contents of the pack Elonva is a clear and colourless aqueous solution for injection (injection) in a pre-filled syringe with an automatic safety system, which prevents needle stick injuries after use.
Slovenian: Zdravilo Elonva je bistra in brezbarvna vodna raztopina za injiciranje (injekcija) v napolnjeni injekcijski brizgi z avtomatskim varnostnim sistemom, ki preprečuje poškodbe zaradi vboda igle.
English: Infertile women undergoing ART have an increased incidence of ectopic pregnancies.
Slovenian: Pri neplodnih ženskah v programu asistirane reprodukcije je povečana incidenca ektopičnih nosečnosti.
English: There is no relevant use of Elonva within the approved indication in the paediatric population.
Slovenian: Glede na odobreno indikacijo uporaba zdravila Elonva pri pediatrični populaciji ne pride v poštev.
English: Following use of Elonva, 61 infants were born after an FTET cycle in the PURSUE study follow-up, and 607 infants were born after fresh ART cycles in the ENSURE, ENGAGE and PURSUE studies combined.
Slovenian: Prirojene malformacije, o katerih so poročali pri otrocih, rojenih po ciklu FTET Po uporabi zdravila Elonva se je rodilo 61 otrok po FTET ciklu v nadaljevanju študije PURSUE in 607 otrok po ART ciklu s svežimi zarodki skupno v študijah ENSURE, ENGAGE in PURSUE.
English: Driving and using machines Elonva may cause dizziness.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Elonva lahko povzroči omotico.
English: In the treatment of women of reproductive age, the dose of Elonva is based on weight and age.
Slovenian: Za zdravljenje žensk v rodni dobi se odmerek zdravila Elonva določi glede na telesno maso in starost.
English: Before starting treatment, the couple's infertility should be assessed as appropriate.
Slovenian: Pred začetkom zdravljenja je treba pri paru oceniti, ali je njuna neplodnost sploh primerna za tovrstno zdravljenje.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per injection, i.e. essentially ‘sodium-free'.
Slovenian: Zdravilo Elonva vsebuje natrij To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na injekcijo, kar v bistvu pomeni 'brez natrija'.
English: Not recommended with a GnRH agonist protocol
Slovenian: Zdravljenje skupaj z agonistom GnRH ni priporočljivo
English: In all three studies, treatment with a single injection of Elonva, 100 or 150 micrograms, for the first seven days of COS, resulted in a higher number of oocytes retrieved compared with a daily dose of recFSH.
Slovenian: V vseh treh študijah je zdravljenje z eno injekcijo zdravila Elonva (100 ali 150 mikrogramov) v prvih sedmih dneh COS doseglo večje število dobljenih jajčec, kot je bilo doseženo z dnevnim odmerkom (rek)FSH.
English: 1) and is similar after administration of 100 micrograms corifollitropin alfa to women with a body weight less than or equal to 60 kilograms and of 150 micrograms corifollitropin alfa to women with a body weight greater than 60 kilograms.
Slovenian: 100 mikrogramov korifolitropina alfa ženskam s telesno maso 60 kilogramov ali manj in po dajanju 150 mikrogramov korifolitropina alfa ženskam s telesno maso, večjo od 60 kilogramov.
English: In rare instances, blood clots (thrombosis) that formed inside a blood vessel, broke off, and travelled inside the bloodstream to block another blood vessel (thromboembolism) have been associated with Elonva therapy as with other gonadotropins.
Slovenian: V redkih primerih so bili z zdravilom Elonva, tako kot z ostalimi gonadotropini, povezani krvni strdki (trombi), ki nastanejo znotraj krvne žile, se odtrgajo in potujejo po krvnem obtoku in zamašijo drugo krvno žilo (tromboembolizem).
English: Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, Section 4.2).
Slovenian: Predpisovanje in izdaja zdravila je le na recept s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
English: Elonva is supplied in pre-filled syringes that have an automatic safety system to help prevent needle stick injuries after use.
Slovenian: Zdravilo Elonva je na voljo v napolnjenih injekcijskih brizgah z avtomatskim varnostnim sistemom, ki preprečuje poškodbe zaradi vboda igle po uporabi.
English: Pregnancy from the fresh cycles of ENGAGE and PURSUE
Slovenian: Nosečnost iz ciklov z uporabo svežih zarodkov v študijah ENGAGE in PURSUE
English: Adherence to the recommended Elonva dose and treatment regimen and careful monitoring of ovarian response is important to reduce the risk of OHSS.
Slovenian: Za zmanjšanje tveganja za nastanek OHSS je pomembno upoštevanje priporočenega odmerka zdravila Elonva in režima zdravljenja, ter skrbno spremljanje odziva jajčnikov pri ženski.
English: Dose In the treatment of women of reproductive age, the dose of Elonva is based on weight and age.
Slovenian: Odmerjanje Za zdravljenje žensk v rodni dobi se odmerek zdravila Elonva določi glede na telesno maso in starost.
English: Common (may affect up to 1 in 10 women) - Ovarian hyperstimulation syndrome (OHSS) - Pelvic pain - Feeling sick (nausea) - Headache - Pelvic discomfort - Breast tenderness - Tiredness (fatigue)
Slovenian: Pogosti (pojavijo se lahko pri največ 1 od 10 uporabnic) - sindrom hiperstimulacije jajčnikov (OHSS) - bolečine v medenici - občutek slabosti (siljenje na bruhanje) - glavobol - neugodje v medenici - občutljivost dojk - utrujenost
English: Other ingredients: sodium citrate, sucrose, polysorbate 20, methionine, sodium hydroxide (for pH adjustment), hydrochloric acid (for pH adjustment), water for injections.
Slovenian: Pomožne snovi: natrijev citrat, saharoza, polisorbat 20, metionin, natrijev hidroksid (za uravnavanje pH), klorovodikova kislina (za uravnavanje pH), voda za injekcije.
English: This medicinal product contains less than 1 mmol (23 mg) sodium per injection, i.e., essentially ‘sodium-free'.
Slovenian: Pomožna(e) snov(i) z znanim učinkom: To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na injekcijo, kar v bistvu pomeni 'brez natrija'.
English: Additional injections of Elonva should not be given within the same treatment cycle.
Slovenian: V istem ciklusu zdravljenja ženska ne sme prejeti dodatnih injekcij zdravila Elonva.
English: Hepatic metabolism contributes to a minor extent to the elimination of corifollitropin alfa.
Slovenian: Tudi presnova v jetrih prispeva k izločanju korifolitropina alfa, vendar v majhni meri.
English: PURSUE (35-42 years of age) (body weight greater than or equal to 50 kg)
Slovenian: PURSUE (35-42 let starosti) (telesna masa 50 kg ali več)
English: The primary efficacy endpoint in the PURSUE study was vital pregnancy rate defined as the percentage of subjects with at least one foetus with heart activity assessed 5 to 6 weeks after embryo transfer.
Slovenian: Primarni opazovani dogodek učinkovitosti v študiji PURSUE je bil delež vitalnih nosečnosti, tj. odstotek žensk z vsaj enim plodom z delujočim srcem, ocenjen od 5 do 6 tednov po prenosu zarodka.
English: This may be continued for a few days until enough follicles of adequate size are present.
Slovenian: To bo lahko trajalo nekaj dni, dokler ne bo vidnih dovolj foliklov zadostne velikosti, kar bo zdravnik lahko preveril z ultrazvočno preiskavo.
English: Elonva is used in women having infertility treatment like in vitro fertilisation (IVF).
Slovenian: Zdravilo Elonva se uporablja pri ženskah, ki se zdravijo zaradi neplodnosti, na primer z in vitro fertilizacijo (IVF).
English: After administration of Elonva, no additional FSH-containing product should be administered prior to stimulation day 8 (see also section 4.2).
Slovenian: Po prejemu zdravila Elonva ženski pred 8. dnevom stimulacije ne smete dati dodatnega zdravila, ki vsebuje FSH (glejte tudi poglavje 4.2).
English: Vital pregnancy rate Ongoing pregnancy rate
Slovenian: Delež vitalnih nosečnosti Delež potekajočih nosečnosti Delež živorojenih*
English: In the ENGAGE study, non-inferiority was demonstrated in ongoing pregnancy rates between Elonva and recFSH, with ongoing pregnancy rate defined as presence of at least one foetus with heart activity assessed at least 10 weeks after embryo transfer.
Slovenian: V študiji ENGAGE so neinferiornost dokazali s primerjavo deležev potekajočih nosečnosti med zdravilom Elonva in (rek)FSH, pri čemer je bil delež potekajočih nosečnosti opredeljen kot prisotnost vsaj enega ploda z delovanjem srca (ocenjeno vsaj 10 tednov po prenosu zarodka).
English: N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands
Slovenian: Organon Kloosterstraat 6 5349 AB Oss Nizozemska
English: Nervous system disorders
Slovenian: Zapleti žilnega sistema
English: Hypersensitivity reactions, both local and generalised, including rash*
Slovenian: Bolezni imunskega sistema neznana pogostnost preobčutljivostne reakcije, tako lokalne kot generalizirane, vključno z izpuščajem*
English: In the PURSUE study, non-inferiority was demonstrated in vital pregnancy rate between Elonva and recFSH, with vital pregnancy rate defined as the percentage of subjects with at least one foetus with heart activity assessed 5 to 6 weeks after embryo transfer.
Slovenian: V študiji PURSUE so neinferiornost dokazali s primerjavo deležev vitalnih nosečnosti med zdravilom Elonva in (rek)FSH, pri čemer je bil delež vitalnih nosečnosti opredeljen kot odstotek žensk z vsaj enim plodom z delujočim srcem (ocenjeno od 5 do 6 tednov po prenosu zarodka).
English: Table 2: Pregnancy Results from the Fresh Cycles of ENGAGE and PURSUE Intent-to-Treat Population (ITT)
Slovenian: Preglednica 2: Rezultati nosečnosti iz ciklov z uporabo svežih zarodkov v študijah ENGAGE in PURSUE Populacija z namenom zdravljenja (ITT)
English: Pregnancy, puerperium and perinatal conditions
Slovenian: Motnje v času nosečnosti, puerperija in perinatalnem obdobju občasni spontani splav
English: o have previously had a treatment cycle of controlled stimulation of the ovaries that resulted in the growth of more than 30 follicles with a size of 11 mm or larger o have a basal antral follicle count (the number of small follicles present in your ovaries at the beginning of a menstrual cycle) higher than 20
Slovenian: o če imate bazalno število antralnih foliklov (število majhnih foliklov, ki so navzoči v jajčnikih ob začetku menstrualnega ciklusa) večje od 20.
English: Ovarian and other reproductive system neoplasms
Slovenian: Novotvorbe na jajčnikih in na drugih delih reproduktivnega sistema
English: There have been reports of ovarian and other reproductive system neoplasms, both benign and malignant, in women who have undergone multiple treatment regimens for infertility treatment.
Slovenian: Poročali so o nastanku tako benignih kot malignih novotvorb na jajčnikih in na drugih delih reproduktivnega sistema pri ženskah, ki so prejele več shem zdravljenja neplodnosti.
English:  Fibroid tumours of the uterus incompatible with pregnancy.
Slovenian: - če imate fibroidne tumorje v maternici, ki onemogočajo normalno nosečnost.
English: Elonva may cause dizziness.
Slovenian: Zdravilo Elonva lahko povzroči omotico.
English: - Keep this leaflet.
Slovenian: - Pokrovček pustite na igli.
English: Do not use Elonva if you: - are allergic (hypersensitive) to corifollitropin alfa or any of the other ingredients of this medicine (listed in section 6) - have cancer of the ovary, breast, uterus, or brain (pituitary gland or hypothalamus) - have recently had unexpected vaginal bleeding, other than menstrual, without a diagnosed cause - have ovaries that do not work because of a condition called primary ovarian failure - have ovarian cysts or enlarged ovaries - have malformations of the sexual organs which make a normal pregnancy impossible - have fibroid tumours in the uterus which make a normal pregnancy impossible - have risk factor of OHSS (OHSS is a serious medical problem that can happen when the ovaries are overly stimulated.
Slovenian:  Preobčutljivost na učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1,  tumorji jajčnikov, dojk, maternice, hipofize ali hipotalamusa,  nenormalne (tj. nemenstrualne) vaginalne krvavitve brez znanega oz. diagnosticiranega vzroka,  primarna odpoved jajčnikov,  ciste na jajčnikih ali povečani jajčniki,  fibroidni tumorji maternice, ki so nezdružljivi z nosečnostjo,  malformacije reproduktivnih organov, ki so nezdružljive z nosečnostjo,  dejavniki tveganja za sindrom hiperstimulacije jajčnikov (OHSS):
English: 150 micrograms 150 micrograms
Slovenian: Ni raziskano 150 mikrogramov 150 mikrogramov
English: - Release your thumb from the plunger - The needle will withdraw automatically into the syringe where it will be locked permanently.
Slovenian: - Igla se bo samodejno umaknila v injekcijsko brizgo in bo ostala v njej zaprta.
English: Manufacturers N.V. Organon, Kloosterstraat 6, 5349 AB Oss, The Netherlands.
Slovenian: Organon, Kloosterstraat 6, 5349 AB Oss, Nizozemska
English: Number of oocytes retrieved
Slovenian: Število dobljenih jajčec
English: The primary efficacy endpoint was number of oocytes retrieved.
Slovenian: Primarni opazovani dogodek učinkovitosti je bilo število dobljenih jajčec.
English: N.V. Organon
Slovenian: Organon
English: - Keep the syringe pointing upwards - Remove the needle shield straight up and discard it - BE CAREFUL with the needle.
Slovenian: - Z igle naravnost navzgor snemite pokrovček in ga zavrzite.
English: Do not use Elonva - if it has been stored out of the refrigerator for more than one month.
Slovenian: Ne uporabljajte zdravila Elonva - če je bilo shranjeno zunaj hladilnika več kot en mesec, - če je bilo shranjeno zunaj hladilnika pri temperaturi več kot 25 ºC, - če opazite, da raztopina ni bistra, - če opazite, da sta injekcijska brizga ali igla poškodovani.
English:  Malformations of the reproductive organs incompatible with pregnancy.
Slovenian: - če imate anomalije spolnih organov, ki onemogočajo normalno nosečnost.
English: There is an increased chance of having twins or even more than two babies, even when only one embryo is transferred into the uterus.
Slovenian: Tudi v primeru, ko je bil v maternico prenesen le en zarodek, je večja verjetnost, da bo ženska rodila dvojčka ali celo več otrok.
English: Other medical conditions
Slovenian: Druga bolezenska stanja
English: Fresh Cycles of PURSUE (35-42 years of age) (body weight greater than or equal to 50 kg)
Slovenian: Cikli z upotabo svežih zarodkov v študiji PURSUE (35-42 let starosti) (telesna masa 50 kg ali več)
English: Musculoskeletal and connective tissue disorders
Slovenian: Bolezni mišično-skeletnega sistema in vezivnega tkiva občasni bolečina v hrbtu
English: 1) postdose.
Slovenian: 1) in je podobna po dajanju
English: Pituitary suppression with a GnRH antagonist (ganirelix acetate injection at a daily dose of 0.25 mg) was used in each of the three clinical trials.
Slovenian: V vseh treh kliničnih preskušanjih so zavirali delovanje hipofize z antagonistom GnRH (injekcija ganireliksacetata v dnevnem odmerku 0,25 mg).
English: Abdominal distension, vomiting, diarrhoea, constipation
Slovenian: Bolezni prebavil pogosti slabost občasni napihnjenost trebuha, bruhanje, driska, zaprtje
English: The median total duration of stimulation was 9 days for both groups, indicating that one day of recFSH was required to complete ovarian stimulation from stimulation day 8 onwards (no recFSH was given on the day of hCG for this study).
Slovenian: To kaže, da je bil za popolno stimulacijo jajčnikov od 8. dne stimulacije naprej potreben en dan uporabe (rek)FSH (v tej študiji na dan uporabe hCG ni bil prejet (rek)FSH).
English: Your doctor will do ultrasound scans of your ovaries to carefully monitor the number of maturing follicles.
Slovenian: Za skrbno spremljanje števila zorečih foliklov bo zdravnik opravil ultrazvočni pregled jajčnikov.
English: - Hold the syringe with the grey cap pointing upwards - Tap the syringe gently with your finger to help air bubbles rise to the top.
Slovenian: - S prstom nežno potrkajte po injekcijski brizgi, da bodo na vrh priplavali mehurčki zraka.
English: Twisting of the ovary could cause the blood flow to the ovary to be cut off.
Slovenian: Torzija jajčnikov Torzija jajčnikov pomeni zasuk jajčnikov, kar lahko povzroči prekinitev pretoka krvi do jajčnikov.
English: In the ENSURE study, 396 healthy normal ovulatory women, aged 18 to 36 years with a body weight less than or equal to 60 kg, were treated for one cycle with 100 micrograms of Elonva and pituitary suppression with a GnRH antagonist as part of an ART program.
Slovenian: V študiji ENSURE so pri 396 zdravih ženskah z normalno ovulacijo, starih od 18 do 36 let in s telesno maso 60 kg ali manj, v okviru programa ART opravili en ciklus zdravljenja s 100 mikrogrami zdravila Elonva in z zaviranjem hipofize z antagonistom GnRH.
English: Elonva is available in two strengths: 100 micrograms and 150 micrograms solution for injection.
Slovenian: Zdravilo Elonva je na voljo v dveh jakostih: Elonva 100 mikrogramov raztopina za injiciranje in Elonva 150 mikrogramov raztopina za injiciranje.
English:  Tumours of the ovary, breast, uterus, pituitary or hypothalamus.
Slovenian: - če imate rak jajčnikov, dojk, maternice ali možganov (hipofize ali hipotalamusa).
English: ENGAGE (18-36 years of age) (body weight greater than 60 kg and less than or equal to 90 kg)
Slovenian: ENGAGE (18-36 let starosti) (telesna masa več kot 60 kg do vključno 90 kg)
English: Multiple pregnancies and births have been reported for all gonadotropin treatments, including Elonva.
Slovenian: Pri vseh vrstah zdravljenja z gonadotropini, vključno z zdravilom Elonva, so poročali o večplodnih nosečnostih in rojstvu več otrok.
English: Each pre-filled syringe contains 0.5 mL solution for injection.
Slovenian: Vsaka napolnjena brizga vsebuje 0,5 ml raztopine za injiciranje.
English: Elonva 150 µg recFSH 300 IU
Slovenian: Elonva 150 µg
English: In the ENGAGE Study, 1,506 healthy normal ovulatory women, aged 18 to 36 years with a body weight greater than 60 kg and less than or equal to 90 kg, were treated for one cycle with 150 micrograms of Elonva and pituitary suppression with a GnRH antagonist as part of an ART program.
Slovenian: V študiji ENGAGE so pri 1.506 zdravih ženskah z normalno ovulacijo, starih od 18 do 36 let in s telesno maso od 60 kg do vključno 90 kg, v okviru programa ART opravili en ciklus zdravljenja s 150 mikrogrami zdravila Elonva in z zaviranjem hipofize z antagonistom GnRH.
English: PRE-FILLED SYRINGE LABEL
Slovenian: NALEPKA NA NAPOLNJENI INJEKCIJSKI BRIZGI
English: In rare cases, severe OHSS may be life-threatening.
Slovenian: V redkih primerih je lahko hud OHSS življenjsko nevaren, zato je natančen zdravniški nadzor zelo pomemben.
English: The median total duration of stimulation was 9 days for both groups, indicating that two days of recFSH were required to complete ovarian stimulation from stimulation day 8 onwards (recFSH was given on the day of hCG for this study).
Slovenian: To kaže, da sta bila za popolno stimulacijo jajčnikov od 8. dne stimulacije naprej potrebna dva dneva uporabe (rek)FSH (v tej študiji sta bila (rek)FSH in hCG prejeta isti dan).
English: Storage by the patient
Slovenian: Shranjevanje doma
English:  Abnormal (not menstrual) vaginal bleeding without a known/diagnosed cause.
Slovenian: - če ste imeli pred kratkim nepričakovano krvavitev iz nožnice, razen menstruacijske, brez ugotovljenega vzroka.
English: ENSURE (18-36 years of age) (body weight less than or equal to 60 kg)
Slovenian: ENSURE (18-36 let starosti) (telesna masa 60 kg ali manj)
English: In the PURSUE study, 1,390 healthy normal ovulatory women, aged 35 to 42 years with a body weight greater than or equal to 50 kg, were treated for one cycle with 150 micrograms of Elonva and pituitary suppression with a GnRH antagonist as part of an ART program.
Slovenian: V študiji PURSUE so pri 1.390 zdravih ženskah z normalno ovulacijo, starih od 35 do 42 let in s telesno maso 50 kg ali več, v okviru programa ART opravili en ciklus zdravljenja s 150 mikrogrami zdravila Elonva in z zaviranjem hipofize z antagonistom GnRH.